Aarkstore Enterprise - Point of Care Diagnostic Testing World Markets

FOR IMMEDIATE RELEASE
(Free-Press-Release.com) November 4, 2011 -- Point of Care Diagnostic Testing World Markets
http://www.aarkstore.com/reports/Point-of-Care-Diagnostic-Testing-World-Markets-1337.html

Point of care testing (POCT) enables rapid diagnostic tests to be performed while the patient is at the point of care facility where results can be obtained immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs of abuse screening, urine strips testing, pregnancy testing, fecal occult blood analysis, food pathogens screening, hemoglobin diagnostics, infectious disease testing and cholesterol screening. This Company Publications report describes latest developments in the point of care testing market segment. It examines clinical instruments, devices and reagents and supplies as utilized in near-patient environments like hospital emergency rooms, critical care units, clinics and doctor's offices. The study defines the dollar volume of point of care sales and makes five year projections--both in the U.S. and worldwide--including Europe, Asia and Latin America. It also examines in detail the point of care sector for 25 individual country markets. A detailed summary of all important instruments in each clinical market is provided with emphasis on newly introduced products. Moreover, parallel areas where rapid detection is important using hand-held devices such as rapid detection of food pathogens and infectious diseases (MRSA, herpes simplex, avian flu, West Nile virus and typhoid) are discussed. Growth moderators and developing trends in point of care applications, as well as technology platform innovations and connectivity questions are examined in detail. The report surveys almost all of the companies known to be marketing, manufacturing or developing instruments and reagents for the point of care market in the U.S. and worldwide. Each company is discussed in depth, with a section on its history, product lines, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included.
Table of Contents :
1. Overview 14
1.1 About this Report 14
1.2 Scope of the Report 15
1.3 Objectives 16
1.4 Methodology 16
1.5 Executive Summary 17

2. Overview of Diagnostic Testing Point of Care 21
2.1 Point of Care Testing Sites 21
2.2 Point of Care Market Structure 22
2.3 New Directions in Clinical IVD Testing 22

3. POCT and Rapid Testing Market Analysis: Size, Background Analysis, Growth, Share and Competitors 25
3.1 Global POCT Market 31
3.2 U.S. POCT Market 34
3.3 European POCT Market 37

3.3.1 German POCT Diagnostic Market 43
3.3.2 U.K. POCT Diagnostic Market 45
3.3.2.1 U.K. POCT Market Statistics 45
3.3.2.2 U.K. Competitive Analysis 47
3.3.2.3 U.K. Market Access 48
3.3.3 French POCT Diagnostic Market 48
3.3.4 Italian POCT Diagnostic Market 49
3.3.5 Spanish POCT Diagnostic Market 51
3.3.6 Scandinavian POCT Diagnostic Market 52
3.3.7 Swedish POCT Diagnostic Market 53
3.3.8 Finnish POCT Diagnostic Market 54
3.3.9 Norwegian POCT Diagnostic Market 55
3.3.10 Swiss POCT Diagnostic Market 56
3.3.11 Dutch POCT Diagnostic Market 57

3.3.12 Belgian POCT Diagnostic Market 58
3.3.13 Portuguese POCT Diagnostic Market 59
3.3.14 Austrian POCT Diagnostic Market 60
3.3.15 Greek POCT Diagnostic Market 61
3.3.16 Polish POCT Diagnostic Market 62
3.3.17 Czech Republic POCT Diagnostic Market 63
3.3.18 Turkish POCT Diagnostic Market 64
3.4 Asian POCT Markets 64
3.4.1 Japanese POCT Diagnostic Market 64
3.4.2 Indian POCT Diagnostic Market 66
3.4.3 Chinese POCT Diagnostic Market 71
3.5 Rest of the World POCT Market 81
3.5.1 Canadian POCT Diagnostic Market 82
3.5.2 Brazilian POCT Diagnostic Market 82

3.5.3 Australian POCT Diagnostic Market 83
3.6 Overview of Asian Healthcare Market 83
3.6.1 Singapore 85
3.6.2 Malaysia 85
3.6.3 Thailand 86
3.6.4 Indonesia 86
3.6.5 Philippines 86
3.6.6 South Korea 87
3.6.7 Taiwan 87

4. POCT Individual Markets 88
4.1 Glucose Testing 88
4.2 POCT Individual Market Sectors, Size, Growth Rates and Competitors 89
4.2.1 World Market Revenue and Forecasts 89
4.2.2 Professional Glucose Testing Market for POCT U.S. Revenue and Forecasts during
2001-2012 90
4.2.3 European Market 91
4.2.4 Market Share 91

4.2.5 Alternate Glucose Monitoring Products 92
4.2.6 HbA1c POCT 93
4.2.7 Market Challenges and Strategic Recommendations 94
4.2.7.1 Market Drivers and Restraints 94
4.2.7.1.1 Market Drivers 94
4.2.7.1.2 Market Restraints 94
4.2.7.2 Point of Care Glucose Testing Assay Market and Technology Trends 95
4.2.7.2.1 Point of Care Glucose Testing Assay Market Trends 95
4.2.7.2.2 Point of Care Glucose Testing Assay Technology Trends 95
4.2.7.2.3 Point of Care Glucose Testing Assay Strategic Recommendations 95
4.3 Blood Gas and Electrolytes 96
4.3.1 Whole Blood Lactate 99

4.4 Rapid Coagulation Tests 99
4.4.1 World POCT Coagulation Market 102
4.4.2 U.S. Coagulation Market 102
4.4.3 European Coagulation Market 106
4.4.4 Trends in POCT Coagulation Testing 106
4.4.4.1 Self-testing Coagulation Market 106
4.4.4.2 D-Dimer Testing 107
4.4.5 Point of Care Coagulation Testing Assay Market and Technology Trends 107
4.4.5.1 Point of Care Coagulation Testing Assay Market Trends 107
4.4.5.2 Point of Care Coagulation Testing Assay Technology Trends 108
4.4.5.3 Point of Care Coagulation Testing Assay Strategic Recommendations 108

4.5 Rapid Cardiac Markers 109
4.5.1 U.S. Market 109
4.5.2 European Market 111
4.5.3 Market Drivers and Restraints 113
4.5.3.1 Market Drivers 113
4.5.3.2 Market Restraints 113
4.5.4 Point of Care Cardiac Marker Testing Assay Market and Technology Trends 113
4.5.4.1 Point of Care Cardiac Marker Testing Assay Market Trends 113
4.5.4.2 Point of Care Cardiac Marker Testing Assay Technology Trends 114
4.5.4.3 Point of Care Cardiac Marker Testing Assay Strategic Recommendations 114
4.6 Drugs of Abuse Screening Testing 114
4.6.1 Acetaminophen 121

4.6.2 Tricyclic Antidepressants (TCAs) 122
4.6.3 Other Toxic Drugs 122
4.6.4 Drug Testing Selectivity 122
4.6.5 Methaqualone and Phencyclidine (PCP) 123
4.6.6 Tetrahydrocannabinol 123
4.6.7 Drug Panels by Toxidromes 123
4.6.8 Alcohol Testing 123
4.7 Urine Strips 124
4.8 Pregnancy Tests 127
4.9 Fecal Occult Blood 128
4.10 Hemoglobin Testing 129
4.11 Miscellaneous Rapid Tests 130
4.11.1 Estriol 130
4.11.2 Fetal Fibronectin (fFN) 131
4.11.3 H. pylori 131
4.11.4 Vaginal pH and Vaginitis 131
4.11.5 Bladder Cancer 132
4.11.6 Fetal Status 133

4.11.7 Heparin-induced Thrombocytopenia 133
4.12 Human Immunodeficiency Virus (HIV) 133
4.13 Cholesterol 140
4.14 Infectious Disease 141
4.14.1 Clostridium difficile 141
4.14.2 Giardia 142
4.14.3 Salmonella and Campylobacter 143
4.14.4 Malaria Testing 143
4.14.5 Influenza Testing 144
4.14.6 Strep Testing 148
4.14.7 Chlamydia 149
4.14.8 Mononucleosis 150
4.14.9 Rubella 150
4.14.10 Methicillin-resistant Staphylococcus aureus (MRSA) 151
4.14.11 Hepatitis 156
4.14.12 Gonorrhea 158
4.14.13 Tuberculosis (TB) 158
4.14.14 Herpes Simplex Virus Type-2 160

4.14.15 Legionella 160
4.14.16 RSV 161
4.14.16.1 Market Drivers and Restraints 163
4.14.16.1.1 Market Drivers 163
4.14.16.1.2 Market Restraints 163
4.14.16.2 Point of Care Infectious Disease Testing Assay Market and Technology Trends 164
4.14.16.2.1 Point of Care Infectious Disease Testing Assay Market Trends 164
4.14.16.2.2 Point of Care Infectious Disease Testing Assay Technology Trends 164
4.14.16.2.3 Point of Care Infectious disease Testing Assay Strategic Recommendations 164
4.15 Infant Jaundice 164
4.16 Anthrax 165

4.17 Rupture of Fetal Membranes (ROM) 167
4.18 Food Pathogens 167
4.19 Typhoid 167

Contact : Marketing Team
Mobil No: +919272852585
Email : contact@aarkstore.com
Website : http://www.aarkstore.com
Email : enquiry@aarkstore.com
http://www.facebook.com/aarkstoreenterprise
http://in.linkedin.com/in/aarkstore

diagnostic     markets     testing     world